Streamlining Research on Controlled Substances Act of 2021

United States117th CongressHR-2405House of Representatives
Updated: Oct 19, 2021

Summary

Streamlining Research on Controlled Substances Act of 2021 This bill makes changes to the registration process for conducting research on controlled substances that are included in schedule I of the Controlled Substances Act. Among the changes, the bill does the following: exempts from the registration requirements an agent or employee of a registered researcher, permits a single registration for contiguous research sites, and requires the Drug Enforcement Administration and the Department of Health and Human Services to review and issue guidance on the processes to obtain or modify federal authorization to conduct research with controlled substances.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

  4. Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

    House of Representatives

All available records shown.